REGIS CORP (RGS)
US7589322061 - Common Stock
We assign a fundamental rating of 2 out of 10 to RGS. RGS was compared to 65 industry peers in the Diversified Consumer Services industry. RGS may be in some trouble as it scores bad on both profitability and health. RGS is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
RGS had negative earnings in the past year.
In the past year RGS has reported a negative cash flow from operations.
RGS had negative earnings in each of the past 5 years.
RGS had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -0.74%, RGS is in line with its industry, outperforming 54.69% of the companies in the same industry.
RGS has a better Return On Invested Capital (3.11%) than 60.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.74% | ||
| ROE | N/A | ||
| ROIC | 3.11% |
ROA(3y)-7.92%
ROA(5y)-7.72%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Operating Margin value of 8.37%, RGS is doing good in the industry, outperforming 67.19% of the companies in the same industry.
In the last couple of years the Operating Margin of RGS has grown nicely.
The Gross Margin of RGS (98.99%) is better than 100.00% of its industry peers.
In the last couple of years the Gross Margin of RGS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.37% | ||
| PM (TTM) | N/A | ||
| GM | 98.99% |
OM growth 3YN/A
OM growth 5Y36.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.05%
GM growth 5Y24.29%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), RGS is destroying value.
The number of shares outstanding for RGS remains at a similar level compared to 1 year ago.
RGS has less shares outstanding than it did 5 years ago.
The debt/assets ratio for RGS is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.06, we must say that RGS is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of RGS (0.06) is worse than 65.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.06 |
ROIC/WACC0.42
WACC7.48%
2.3 Liquidity
RGS has a Current Ratio of 0.31. This is a bad value and indicates that RGS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.31, RGS is not doing good in the industry: 92.19% of the companies in the same industry are doing better.
A Quick Ratio of 0.30 indicates that RGS may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.30, RGS is doing worse than 92.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.31 | ||
| Quick Ratio | 0.3 |
3. Growth
3.1 Past
RGS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -984.75%.
RGS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -53.32%.
Measured over the past years, RGS shows a very negative growth in Revenue. The Revenue has been decreasing by -28.35% on average per year.
EPS 1Y (TTM)-984.75%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-500%
Revenue 1Y (TTM)-53.32%
Revenue growth 3Y-29.63%
Revenue growth 5Y-28.35%
Revenue growth Q2Q-14.86%
3.2 Future
The Earnings Per Share is expected to grow by 18.32% on average over the next years. This is quite good.
The Revenue is expected to decrease by -8.52% on average over the next years.
EPS Next Y41.36%
EPS Next 2Y18.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-10.6%
Revenue Next 2Y-8.52%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
RGS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RGS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, RGS is valued a bit cheaper than 79.69% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 8.67 |
4.3 Compensation for Growth
A more expensive valuation may be justified as RGS's earnings are expected to grow with 18.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.32%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for RGS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
REGIS CORP
NASDAQ:RGS (4/29/2024, 2:05:31 PM)
5.4
-0.25 (-4.42%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap12.31M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.74% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 8.37% | ||
| PM (TTM) | N/A | ||
| GM | 98.99% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.31 | ||
| Quick Ratio | 0.3 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-984.75%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y41.36%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-53.32%
Revenue growth 3Y-29.63%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y